CDKN2B and laryngotracheoesophageal cleft: By combining the results of this experiment with previous related studies [27, 31, 32], we believe that CDKN2B-AS1 and miR-199a-5p can be used as clinical routine screening indicators, so as to improve the early diagnosis rate of LC and provide relevant treatment for patients in a timely manner.